| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 258,9 k € | +101.9% | 128,3 k € | -31.0% | 185,8 k € | +1.7% | 182,7 k € | -28.4% | 255,1 k € | -4.1% | 265,9 k € | +9.7% | 242,3 k € | -3.5% | 251,1 k € | +54.4% | 162,7 k € | -18.1% | 198,5 k € | +8.7% | 182,6 k € | +58.1% | 115,5 k € | -29.5% | 163,7 k € | -18.7% | 201,5 k € | +5.4% | 191,1 k € | +8.4% | 176,3 k € | +2.9% | 171,4 k € | +6.5% | 161,0 k € | -1.1% | 162,8 k € | |
| EBITDA | 206,4 k € | +65.1% | 125,0 k € | +37.1% | 91,2 k € | -33.6% | 137,3 k € | -26.4% | 186,7 k € | +31.8% | 141,6 k € | +14.3% | 123,9 k € | +14.7% | 108,0 k € | +80.0% | 60,0 k € | -51.5% | 123,7 k € | +104.1% | 60,6 k € | +333.3% | 14,0 k € | -59.3% | 34,4 k € | -41.5% | 58,7 k € | +10.7% | 53,1 k € | +30.2% | 40,8 k € | -5.7% | 43,2 k € | +27.2% | 34,0 k € | -32.6% | 50,4 k € | |
| Operating profit | 171,5 k € | +84.8% | 92,8 k € | +56.1% | 59,5 k € | -39.5% | 98,3 k € | -34.4% | 149,8 k € | +39.7% | 107,2 k € | +20.5% | 89,0 k € | +21.8% | 73,1 k € | +25.6% | 58,2 k € | -51.2% | 119,1 k € | +113.4% | 55,8 k € | +529.7% | 8,9 k € | -68.7% | 28,3 k € | -46.1% | 52,5 k € | +28.1% | 41,0 k € | +44.5% | 28,4 k € | +1.3% | 28,0 k € | +42.4% | 19,6 k € | -46.9% | 37,0 k € | |
| Profit/loss | 143,5 k € | +85.2% | 77,5 k € | +104.6% | 37,9 k € | -44.7% | 68,4 k € | -44.5% | 123,4 k € | +41.0% | 87,5 k € | +69.8% | 51,6 k € | -13.7% | 59,7 k € | +39.8% | 42,7 k € | -42.8% | 74,7 k € | +56.0% | 47,9 k € | +118.4% | 21,9 k € | +321.7% | -9,9 k € | -141.6% | 23,8 k € | +27.3% | 18,7 k € | +100.4% | 9,3 k € | -27.4% | 12,8 k € | -22.8% | 16,6 k € | -42.7% | 29,0 k € | |
| Equity | 1,0 M € | +5.9% | 957,2 k € | +4.1% | 919,7 k € | +4.3% | 881,8 k € | +8.4% | 813,4 k € | +9.9% | 740,0 k € | +5.3% | 702,4 k € | +7.9% | 650,9 k € | +10.1% | 591,1 k € | -27.3% | 813,1 k € | +10.1% | 738,4 k € | +0.8% | 732,9 k € | +3.1% | 711,0 k € | +110.9% | 337,1 k € | +7.6% | 313,3 k € | +6.3% | 294,6 k € | -23.5% | 385,3 k € | +3.4% | 372,5 k € | +4.7% | 355,9 k € | |
| Total assets | 1,3 M € | +12.1% | 1,1 M € | +14.0% | 979,7 k € | +3.1% | 950,3 k € | +1.6% | 935,6 k € | +9.8% | 851,9 k € | -3.3% | 881,4 k € | -11.9% | 1,0 M € | +18.1% | 846,9 k € | -12.7% | 970,1 k € | +4.8% | 925,8 k € | -17.7% | 1,1 M € | -0.3% | 1,1 M € | +47.4% | 765,3 k € | +20.5% | 634,8 k € | +11.7% | 568,2 k € | -10.5% | 635,1 k € | +11.4% | 570,0 k € | +19.2% | 478,0 k € | |
| Cash | 140,9 k € | +0.7% | 139,9 k € | -60.9% | 357,7 k € | +46.0% | 245,0 k € | +31.2% | 186,8 k € | +59.9% | 116,8 k € | -4.4% | 122,2 k € | -39.7% | 202,7 k € | -7.0% | 217,9 k € | -46.2% | 405,2 k € | +420.4% | 77,9 k € | +315.3% | 18,7 k € | -69.2% | 60,9 k € | -53.2% | 130,0 k € | +40.4% | 92,7 k € | +41.6% | 65,4 k € | -24.6% | 86,8 k € | -1.8% | 88,3 k € | +8.0% | 81,8 k € | |
| Debts | 237,9 k € | +48.7% | 160,0 k € | +188.8% | 55,4 k € | -19.1% | 68,5 k € | -43.8% | 121,8 k € | +13.9% | 106,9 k € | -31.9% | 157,1 k € | -54.6% | 346,2 k € | +58.2% | 218,8 k € | +39.6% | 156,7 k € | -16.4% | 187,3 k € | -52.2% | 392,0 k € | -5.0% | 412,6 k € | -3.2% | 426,1 k € | +33.5% | 319,1 k € | +18.8% | 268,7 k € | +8.7% | 247,2 k € | +27.2% | 194,3 k € | +64.6% | 118,1 k € | |
| Staff | 0,8 | — | 0,9 | 0,7 | 1 | 1,9 | 1,9 | 2 | 1,6 | 1,2 | 1,5 | 1,5 | 2,3 | 2,6 | 2,6 | 2,6 | 2,6 | 2,6 | 2,4 | |||||||||||||||||||
Private limited company · Affligem · incorporated on 04/10/1984 · 0,8 ETP
Private limited company profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
APOTHEEK ESSENE is a Private limited company incorporated in 1984. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Affligem. It employs on average 0,8 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette